Stem cells have the potential to regenerate and repair damaged tissues. Stem cell therapies help treat chronic diseases such as cancer, diabetes, cardiovascular diseases and neurodegenerative diseases. Stem cells can be obtained from various sources including embryonic stem cells, adult stem cells and induced pluripotent stem cells. The global Stem Cell Manufacturing Market is estimated to be valued at US$ 12.75 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising prevalence of chronic diseases has been a key driver boosting the stem cell manufacturing market growth. As per the statistics by WHO, chronic diseases accounted for over 70% of global deaths in 2019. The increasing research and development activities in stem cell therapies have led to encouraging clinical trial results for treatment of various diseases like diabetes, cancer and heart ailments. This has increased the commercialization and manufacturing of stem cell products. Advancements in technologies related to stem cell processing, storage and isolation have also facilitated large-scale stem cell manufacturing. The industry is witnessing collaborations between stem cell companies and research institutes for developing innovative stem cell treatment approaches.
Segment Analysis
The global stem cell manufacturing market is segmented on the basis of stem cell type, application, end-user and region. Based on stem cell type, the market is divided into adult stem cells, human embryonic stem cells and induced pluripotent stem cells. Among these, the adult stem cells segment held the largest market share in 2024 owing to its higher proliferation and differentiation capabilities. The induced pluripotent stem cells segment is expected to grow at the fastest rate during the forecast period due to the ability of these cells to generate all cell types of the body.
Key Takeaways
The global stem cell manufacturing market is expected to witness high growth during the forecast period of 2024 to 2031.
Regional analysis shows that North America had the highest market share in 2024 due to supportive government initiatives and advancement in stem cell research. Europe is expected to grow at the fastest rate during the forecast period owing to growth in pharmaceutical and biotechnology industries.
Key players operating in the stem cell manufacturing market are Thermo Fisher Scientific, Merck Group, Becton, Dickinson and Company, Lonza Group, Corning Incorporated and others. Thermo Fisher Scientific held the largest market share in 2024 owing to its advanced cell culture media and bioreactor systems for stem cell production and processing. Merck Group is also a prominent player with wide range of reagents and instruments for iPSC generation and differentiation.
No comments:
Post a Comment